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Membranotropic peptideBiological membranes represent a physical barrier that most viruses have to cross for replication. While
enveloped viruses cross membranes through a well-characterized membrane fusion mechanism, non-
enveloped viruses, such as rotaviruses, require the destabilization of the host cell membrane by processes that
are still poorly understood.We have identiﬁed, in the C-terminal region of the rotavirus glycoprotein VP7, a pep-
tide that was predicted to contain amembrane domain and to fold into an amphipathicα-helix. Its structure was
conﬁrmed by circular dichroism in media mimicking the hydrophobic environment of the membrane at both
acidic and neutral pHs. The helical folding of the peptidewas corroborated by ATR-FTIR spectroscopy,which sug-
gested a transmembrane orientation of the peptide. The interaction of this peptidewith artiﬁcial membranes and
its afﬁnity were assessed by plasmon waveguide resonance. We have found that the peptide was able to insert
into membranes and permeabilize them while the native protein VP7 did not. Finally, NMR studies revealed
that in a hydrophobic environment, this helix has amphipathic properties characteristic of membrane-
perforating peptides. Surprisingly, its structure varies from that of its counterpart in the structure of the native
protein VP7, as was determined by X-ray. All together, our results show that a peptide released from VP7 is ca-
pable of changing its conformation and destabilizing artiﬁcialmembranes. Such peptides could play an important
role by facilitating membrane crossing by non-enveloped viruses during cell infection.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Non-enveloped viruses, rotaviruses, are themost important cause of
severe dehydrating viral gastroenteritis in infants and young children
[1]. Rotaviruses are members of the reoviridae family, containing 11
double-stranded RNA gene segments (dsRNA) and replication proteins,
VP1 andVP3,within an icosahedral triple-layer particle (TLP) [2]. The11
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-sur-Yvette, France.depending on the strain, ﬁve or six non-structural proteins [3]. DsRNA
viruses conceal their genome from the innate immune system through
the translocation of a high-molecular weight protein-dsRNA complex
almost as large as the entire virion by a mechanism that still remains
to be experimentally demonstrated. The virion shell contains 780 copies
of the predominant glycoprotein VP7, which are assembled into
calcium-dependent trimers [4]. Superimposed trimers of VP7 and VP6
constitute a T = 13 l (l for levo) icosahedral lattice [5] deﬁning three
types of aqueous channel according to their position with respect to
the icosahedral axes of symmetry [6]. VP4 is anchored in the channels
surrounding the ﬁve-fold axes of the particle and protrudes as a spike
by more than 12 nm from the surface of the particle [7,8]. VP6 consti-
tutes the middle layer of the TLP while 120 molecules of VP2 form its
innermost layer, obeying a T = 1 icosahedral symmetry, with twomol-
ecules in the asymmetric icosahedral unit [9].
The virionmust be activated by proteolysis to be infectious [10]. VP4
is cleaved by trypsin, thereby generating the permeabilizingmembrane
protein VP5* [11,12] and the rotavirus hemagglutinin VP8* [13]. Recent-
ly, electron cryomicroscopy (cryoEM) and single-particle analysis at
about 4.3 Å resolution showed how the two subfragments of VP4,
VP8* and VP5* retain their association after proteolytic cleavage [14].
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ly active double-layered particles (DLP). Only viral proteins constitutive
of the TLP external layer (VP5*, VP8* and VP7) are thought to be in-
volved in the entry process. Their atomic structure has been determined
by X-ray crystallography [15–17]. The trimeric crystal structure of the
rhesus rotavirus VP7 bound with the Fab fragment from a neutralizing
monoclonal was determined [17]. Each subunit of VP7 folds into two
compact domains where each monomer interface binds two calcium
ions [17] that maintain the trimeric structure of VP7 and stabilize the
outer layer [14,18].
The virion enters the target cell in a multi-step process involving
both cellular and viral proteins. VP4 is initially disorganized at the sur-
face of the virus and its proteolytic cleavage generates an organized
rod-like spike [7,8] that binds to a receptor at the cell surface. The mor-
phology of the spikes has been described and reveals that the β-barrel
domains of two subunits form the body and that of the third one
forms the stalk [14]. Several potential receptors have been identiﬁed,
such as various integrins [19,20] and the heat shock protein Hsc70
[21]. It is not known yet whether human rotavirus VP8* interacts with
sialic acid and whether its attachment to the cell involves sialoglycans
[22]. However, the surface spike protein VP8* from human rotavirus
and the majority of animal rotaviruses interact with the secretor
histo-blood group antigens (HBGAs) [23]. It has been suggested that a
direct entry into the cell occurs after adsorption onto the cell surface,
via the plasmamembrane [24], but it seemsmore likely that rotaviruses
enter cells through a dynamin-dependentmechanismbased onendocy-
tosis [25]. Isolated VP5* in solution undergoes another structural
change, in which three VP5* join together to form a tightly associated
trimer [16,26] that binds to lipid bilayers [27] and permeabilizes them
[12]. The uncoating of VP7, caused by the removal of calcium, probably
accompanies the penetration of the virion and its activation [16].
Membrane-destabilizing peptides are produced by members of dif-
ferent virus families: nodaviridae [28–30], birnaviridae [31,32] and
reoviridae [33–35]. In many cases, these peptides were thought to be
associated to virus entry [29,31] and amechanismof pore formation ap-
pears to depend on those peptides.While some pores form beta-barrels
by assembly of beta-hairpins [34] as many anti-microbial peptides [36]
others are formed by α-helices [31]. In all cases, the sequential events
constituting the pore formation are not well characterized.
In this work, we identiﬁed a domain in the C-terminal region of VP7,
predicted to contain a membrane-interacting domain that adopts an
amphipathic α-helical structure when inserted into membranes. We
showed that this peptide interacts with artiﬁcial membranes and
renders the membrane semipermeable. Circular dichroism (CD), plas-
mon waveguide resonance (PWR) and ATR-FTIR spectroscopy were
employed to monitor the structure of the isolated peptide, its interac-
tion and its afﬁnity for lipids as well as its orientation in respect to the
lipid surface. The solution structure of this domain was determined by
nuclear magnetic resonance (NMR) and compared to its corresponding
domain in the native protein VP7 [17]. Our data show that this domain
undergoes a large structural rearrangement. If ever released from the
native protein VP7, this peptide, in associationwith VP5*, could destabi-
lize membranes and facilitate their permeabilization.
2. Material and methods
2.1. Bioinformatics analysis and peptide synthesis
Membrane domain prediction on the glycoprotein VP7 was per-
formed with the Mpex program (Membrane Protein Explorer), a tool
for exploring the topology of membrane proteins bymeans of hydropa-
thy plots based upon thermodynamics [37] and with the PHD program
predicting one-dimensional protein structure by proﬁle-based neural
networks [38]. Protein secondary structure prediction was achieved
on the full glycoprotein VP7 using the Web server called NPS@ (Net-
work Protein Sequence Analysis, http://pbil.ibcp.fr/NPSA) [39].2.2. Materials
The identiﬁed peptide containing 31 amino acids, and predicted to
adopt an alpha helical structure, was extended by 14 and 16 amino
acids on the N- and the C-terminal sides respectively to incorporate
the predicted β-strands. The obtained peptidewith a ﬁnal size of 61 res-
idues is referred to as VP761. The peptide VP761 from the human rotavi-
rus (B223 strain, Q3ZK60-1 in the Swiss Prot database), purchased from
Proteogenics (Oberhausbergen, France), was synthesized by the auto-
mated solid phase method with the Fmoc strategy and puriﬁed by
reverse-phase HPLC.
2.3. Circular dichroism (CD)
CD spectra were recorded at room temperature (20 °C) in a 0.1 cm
path length quartz cell on a Jobin-Yvon model C8 spectropolarimeter
calibrated with d-camphor-10-sulfonate. The experiments were per-
formed at pH 3.3 and 7.4 with 3 mM of DPC micelles in 1× PBS buffer
and the peptide concentration in each samplewas 30 μM. Four averaged
scans were collected in 0.5 nm interval steps, using an integration time
of 2 s and a light bandpass or slit width of 2 nm. Curves were smoothed
from 200 to 260 nm using 25 data points. Respective intensities are
expressed in mean residue molar ellipticity [θ], calculated from the
equation [θ] = 100[θ]obs/CnL, where [θ]obs is the observed ellipticity
in millidegrees (mdeg), L is the optical path length in centimeters
(0.1 cm), C is the ﬁnal concentration of the peptide in molar and n is
the number of amino acid residues.
2.4. Plasmon waveguide resonance (PWR)
PWR experiments were performed on a beta PWR instrument (from
Proterion Corp., Piscataway, NJ) that had a spectral angular resolution of
1 mdeg. Resonances can be obtained with light whose electric vector is
either parallel (s-polarization) or perpendicular (p-polarization) to the
plane of the resonator surface. The sample to be analyzed (a lipid bilayer
membrane) was immobilized on the resonator surface and placed in
contactwith an aqueousmedium, intowhich the peptideswere then in-
troduced. The self-assembled lipid bilayer was formed using a solution
(in butanol/squalene, 0.93:0.07, v/v) of 8 mg/ml egg phosphatidylcho-
line (Avanti Polar Lipids). The method used to prepare the lipid bilayer
is based on the procedure byMueller and Rudin [40] tomake black lipid
membranes cross a small hole in a Teﬂon block: the method has been
reported [41,42]. The buffer used for the experiments was Tris-buffer
(10 mM Tris 0.1 M NaCl, 2 mM EDTA, pH 7.6). Because the peptide
was not completely soluble in the Tris buffer, 5% DMSO was added to
the 1 mM solution of peptide. After bilayer formation, the peptide was
incrementally added to the cell sample compartment and the spectral
changes were monitored with both polarizations. It should be noted
that DMSO perturbs the lipid bilayer, therefore a control experiment
was performed using the same ﬁnal DMSO concentration used for
each peptide solution injected into the cell. The shifts obtained upon
DMSO addition were subtracted from those obtained upon peptide ad-
dition to the lipid bilayer. Afﬁnities between the peptide and the lipids
were obtained by plotting the PWR spectral changes that occur upon in-
cremental additions of ligand to the cell. Data ﬁtting (GraphPad Prism)
through a hyperbolic saturation curve provides the dissociation con-
stants. It should be noted that concomitantly with the binding process
other processes such as membrane reorganization and solvation occur
and thus the dissociation constants correspond to apparent dissociation
constants. Spectral simulation [41] and/or graphical analysis [43] allows
one to obtain information about changes in themass density, structural
asymmetry and molecular orientation induced by bimolecular interac-
tions occurring at the resonator surface. Here, the graphical analysis
method was employed. Brieﬂy, this method consists of deconvoluting
the components of the PWR spectra that are due to changes in mass
in the lipid ﬁlm from those that are due to changes in structural
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not be further described here [43]. Such distinction can be done based
on the magnitude and direction of the PWR spectra shifts observed for
the s- and p-polarized light. The method has been employed to analyze
the interaction of peptides with lipid membranes [31,44–46].
2.5. ATR-FTIR spectroscopy
Infrared spectra were recorded with a Nicolet 6700 FT-IR spec-
trometer (Nicolet Instrument, Madison, WI) equipped with a liquid
nitrogen cooled mercury–cadmium–telluride detector. Lipid bilayers
were formed by the fusion of SUVs onto the ATR germanium crystal of
a Miracle Cell (Spike Technology). Ten microliters of 3 mg/mL EggPC
SUVs lipid solution in PBS buffer were deposited on the crystal via the
Teﬂon cell at room temperature. After 10–15 min, the non-adsorbed
lipids were rinsed 5 times with 20 μL of PBS buffer, and ﬁnally 20 μL
of PBS buffer were added in the Teﬂon cell before the polarized s- and
p-ATR-FTIR spectrawere recorded. The polarized spectrawere obtained
using a motorized rotating wire-grid polarizer. Once the bilayer was
formed, the peptide was injected in the solution to reach 1 μM. The
ATR spectra were recorded at room temperature and 800 scans at
8 cm−1 spectral resolution were co-added.
2.6. Fluorescence assay
Liposomes containing carboxyﬂuorescein (CF) were prepared as
previously described [11]. The release of CF after addition of the peptide
was monitored by assessing the increase in ﬂuorescence at 520 nm,
with excitation at 492 nm in a thermostatically controlled Perkin-
Elmer LS50B spectroﬂuorimeter. The value for 100% release was obtain-
ed by adding Triton X-100 at the end of the reaction. All ﬂuorescence
experiments were carried out at least three times. The ﬂuorescent
probe used in the experiments, CF, has an extra carboxyl group relative
to ﬂuorescein, making the molecule more polar and less capable of
crossing membranes at pH 7.4 at low phosphate buffer concentration
[47]. Thus all ﬂuorescence assay experiments were conducted at
pH 7.4, because at this pH the effect on passive diffusion of CF through
the membrane liposomes is weak.
2.7. Sample preparation for NMR experiments
For NMR sample preparation, 4.4 mg of VP761 was dissolved in a
CD3OH/CDCl3 (1:1, v/v) mixture or in 500 μl of water with 100 mM of
dodecylphosphatidylcholine (DPC) to give a 1 mM ﬁnal concentration
of the peptide at pH 3.3. NMR experiments were performed at various
temperatures ranging from 293 K to 323 K on an AVANCE Bruker spec-
trometer operating at 600.13 MHz. Phase-sensitive 1H DQF-COSY [48]
and TOCSY [49] experiments with a 70 and 80 ms spin lock duration
were recorded. NOESY experiments [50] were performed at three
different mixing times of 100, 200 and 250 ms. Experiments were re-
corded with a 7788.16 Hz spectral width, 2048 real points in t2, and
512 t1-increments. A π/6 phase-shifted sine bell window function was
applied prior to Fourier transformation in both dimensions (t1 and
t2). The temperature was controlled externally with a Bruker BCU 05
chiller. Data were processed with Topspin 1.3 software (Bruker) and
analyzed with SPARKY (T.D. Goddard and D.G. Kneller, UCSF, San
Francisco, CA) or CcpNmr Analysis [51].
2.8. Assignment and structure calculation
All proton resonanceswere assigned by awidely described homonu-
clear 2D NMR spectroscopy strategy [52] based on the identiﬁcation of
individual amino-acid spin systems revealed by the DQF-COSY and the
TOCSY experiments. In a second step, the amino-acid spin systems
were correlated through the information extracted from the NOESY
spectra performed at different mixing times.The structure of VP761 in CDCl3/CD3OH (1:1, v/v)was determined by
using the distance restraints obtained from Nuclear Overhauser Effect
(NOE) cross-signal volumes measured on the NOESY spectra recorded
at 293 K with 100 ms and 200 ms mixing time. Peaks were integrated
and converted into distances on the basis of an r−6 dependence, with
a tolerance of 20%. Distanceswere calibrated using cross-peaks between
the aromatic protons (Hδ, Hε) of Y323 and Y324, which have a known
distance of 2.45 Å. Distance geometry and simulated annealing regular-
ization were performed to embed and optimize the initial structures
using the software XPLOR-NIH [53]. The 20 best structures generated
in 100 attempts at embedding and optimization were selected based
on satisfactory covalent geometry, low distance restraint violations
and favorable non-bonded energy. These structures were further opti-
mized by restrained molecular dynamics, in vacuum, with a distance-
dependent dielectric constant, as previously described [54], and were
evaluated for stereochemical quality by PROCHECK-NMR [55].
The structure calculation of VP761 in DPC was performed with CNS
version 1.2 [56] using ARIA v.2.3 [57], frommanually assigned 1H-1H re-
straints derived from 200 and 250 ms mixing time NOESY spectra at
323 K. The standard annealing protocols were used, including NOE dis-
tance calibration. The starting structureswere generated based on a lin-
ear templatemoleculewith randomly associated velocities for all atoms.
For iterations 1–7, 200 structures were calculated and the NOE distance
restraints were recalibrated by ARIA based on the 100 lowest energy
structures. The violation tolerance was progressively reduced to 0.1 Å
in the last iteration (iteration 8), in which 80 structures were calculated.
For the structure calculations, a ﬁve-stage simulated annealing (SA) pro-
tocol was used employing cartesian dynamics. The high-temperature
stage consisted of 10,000 steps at 10,000 K, followed by three cooling
stages: 4000 steps to 2000 K, 5000 steps to 1000 K and 4000 steps to
50 K. During the SA protocol the force constant for the NOE restraints
was set to 0, 10 and 50 kcal mol−1 Å−2. The ﬁnal 80 structures were
then reﬁned in a shell of water molecules and the eight best structures
were analyzed as the ﬁnal structure ensemble. The Ramachandran
plot statistics of the ﬁnal structure ensemble was analyzed with the
PROCHECK software.
2.9. Accession numbers
The 1H NMR resonance assignments of VP761 identiﬁed in CDCl3/
CD3OH (1:1, v/v) and in DPC have been deposited at the Biological Mag-
netic Resonance Data Bank under accession codes RCSB101627 and
RCSB102553 respectively. The coordinates of the structures calculated
in CDCl3/CD3OH (1:1, v/v) and in DPC have been deposited at the Pro-
teinData Bank (PDB)with accession codes 2KVL and 2LM7 respectively.
3. Results
3.1. A domain in the C-terminal region of VP7 is predicted to adopt an
amphipathic helical structure
Several peptides derived fromVP7 have been shown to interactwith
membranes and destabilize them [58]. We have used bioinformatics
tools to identify a potential membranotropic domain within VP7, capa-
ble of destabilizing artiﬁcial membranes. The full sequence of VP7 was
submitted to secondary structure prediction [37,38,59] andwaspredict-
ed to contain a membrane domain overlaying residues W292-M310 in
its C-terminal region (Fig. 1A). Moreover, an α-helix spanning residues
Q280-M310 and two extended strands L269-I271 and S321-Y324 were
predicted to be surrounded by unstructured loops (Fig. 1B). The predicted
helical membrane domain Q280-M310 was shown to have amphipathic
properties in a helical wheel representationwith the hydrophilic residues
on one side (blue) and the hydrophobic ones (red) on the other side
(Fig. 1C). This peptide was thus extended by 14 and 16 amino acids on
the N- and the C-terminal sides respectively to include all predicted
     |         |         |         |         |         |
|                 |
A
B
C
Fig. 1. Prediction of an amphipathic alpha helix in the C-terminal region of VP7 by a combination of Bioinformatics tools predicting membrane domains [37] and secondary structure el-
ements [39]. (A) The full sequence of VP7 submitted to the programMpex [37] predicted a potential membrane domain spreading residuesW292-M310. (B) The full sequence of VP7was
submitted to the Web server NPS@ (Network Protein Sequence Analysis, http://pbil.ibcp.fr/NPSA) [39], which predicted an alpha helix covering residues Q280-M310 and two extended
strands L269-I271 and S321-Y324 surrounded by unstructured loops. (C) Helical wheel representation showing that the domain Q280-M310 is predicted to adopt an alpha helical struc-
ture with amphipathic properties.
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and is referred to hereafter as VP761.3.2. Circular dichroism shows that VP761 adopts an alpha helical structure
in DPC
CD spectra of VP761were performed at pH 3.3 and pH 7.4 at a concen-
tration of 30 μM, in DPC micellar suspension with a 1/100 peptide/lipid
ratio (Fig. 2). The spectra of VP761 in 3 mMmembrane-mimicking agent
DPC, at pH 7.4 (Fig. 2; red spectra) and at pH 3.3 (Fig. 2; blue spectra)1
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Fig. 2. Circular dichroism spectra of VP761. The spectrum of VP761 (red) in the presence of
membrane-mimicking agents such as DPC with a peptide/lipid ratio 1/100 at pH 7.4, pre-
sents the same typical α-helix structure as at pH 3.3 (blue).present the characteristic negative bands at 209 nm (parallelπ→π* tran-
sitions) and at 222 nm, indicating the formation of anα-helix. The part of
the spectra containing the maximum at 190 nm is not represented be-
cause the signal was saturated by the presence of NaN3 in the PBS buffer.
The two pHs 3.3 and 7.4 have been chosen to demonstrate that the pep-
tideVP761 adopts an alphahelical structurewhatever thepH. Actually, the
helical content seems to be higher at pH 7.4 compared to pH 3.3 since a
lower ellipticity value is measured at acidic pH.3.3. VP761 interacts with artiﬁcial membranes
PWRwas used to follow the interaction of VP761 with the lipid bi-
layer in terms of afﬁnity and changes induced by the peptide on the
lipid bilayer organization and total mass. The addition of VP761 to an
egg PC bilayer led to positive spectral shifts for both p-polarization
(+14 mdeg) and s-polarization (+13 mdeg) (Fig. 3A and B), indi-
cating an increase in the refractive index of the system. This is a nat-
ural consequence of the increase in mass due to peptide interaction,
which can also be associated with a mass increase coming from the
reorganization of the lipid induced by the peptide. The magnitudes
of the changes are comparable to other studies regarding membrane
active peptides [46,60,61]. Washing the PWR cell compartment with
buffer does not lead to the original spectra of the lipid bilayer prior to
peptide addition and thus, the spectral changes induced by the pep-
tide are non-reversible. From the resonance minimum position as a
function of concentration an apparent dissociation constant was de-
termined (details can be found in Section 2, Material and methods
section) and a KD of 95 nM was obtained (Fig. 3C). A graphical analysis
of the spectral shifts observed upon peptide interaction with the mem-
brane indicates that 90% of the spectral changes are due to changes in
mass of the system and the remaining 10% are due to changes in struc-
ture (details on graphical analysismethod are provided in Section 2, Ma-
terial and methods and in Ref. [43]). Additionally the spectral changes
Fig. 3. PWR spectra of the interaction of VP761with an egg PC lipid bilayer. PWR spectra (A and B) obtained for the lipid bilayer before (1) and after (2) addition of VP761 to the bilayerwere
obtained for p- and s-polarized light, respectively. The resonance position shifts obtained for p- (●) and s- (■) polarizations for the incremental addition of VP761 are represented, and so is
the hyperbolic binding curve (C) from which a KD value of 95 nm was obtained.
2030 S. Elaid et al. / Biochimica et Biophysica Acta 1838 (2014) 2026–2035observed for peptide addition are quite similar for both polarizations in-
dicating that similar changes occur in the plane of the lipid bilayer and off
plane.
3.4. VP761, interacting with an EggPC bilayer, folds in an α-helix structure
Polarized ATR infrared spectra of the VP761 peptide in contact with
EggPC bilayer were recorded. The noise is present outside the region
of interest for the assignment of secondary structures and therefore
these spectra are of sufﬁcient quality to be able to assign secondary
structures with certainty. This noise level is normal especially given
the low signal absorption as our group has already published on other
peptides [62]. The peptide was detected by the presence of the Amide
I band between 1700 cm−1 and 1600 cm−1 and the amide II band
around 1550–1540 cm−1 (Fig. 4). The amide I band was centered at
1654 cm−1 which indicates that the peptide is mainly folded in an α-
helix structure. However, other secondary structures are also present
such as a turn deﬁned by a band at 1675 cm−1 and a β-sheet deﬁned
by a band at 1633 cm−1 clearly observed on the p-polarized spectrum
(Fig. 4). The presence of the various structures makes it difﬁcult to de-
termine the peptide orientation from the dichroic ratio of the bands.
However, the large intensity of the amide I in p-polarization suggests
that the peptide folds in anα-helix with a trans membrane orientation.
3.5. VP761 induces membrane destabilization
The release of ﬂuorescent molecules from the liposomes containing
quenched carboxyﬂuorescein increased strongly upon the addition ofFig. 4.ATR-FTIR spectroscopy of VP761 in interactionwith an egg PC lipid bilayer. Polarized
ATR infrared spectra of theVP761 peptidewith bilayer of EggPC lipids is reported. The pep-
tide was detected by the presence of the Amide I band between 1700 and 1600 cm−1 and
the amide II band around 1550–1540 cm−1. The amide I band centered at 1654 cm−1 in-
dicates that the peptide ismainly folded in α-helix. However, turn (1675 cm−1) and beta-
sheet (1633 cm−1) structures are also present and clearly observed on the p-polarized
spectrum.VP761 (Fig. 5), revealing the release of the carboxyﬂuorescein from the
liposomes. Both speed and magnitude of liposome destabilization
depended on the concentration of VP761 and the increase in ﬂuores-
cence reached saturation atmicromolar concentrations of VP761. Partic-
ular solvent conditionswere used in order to prevent VP761 tendency to
aggregate or oligomerize in aqueous solutions. Indeed, the peptide was
solubilized in DMSO (at high concentration) and diluted with buffer for
the various experiments. At low nanomolar concentrations, VP761 leads
to a signiﬁcant leakage of the liposomes whereas DMSO does not
(Fig. 5).
3.6. Solvent condition optimization for the structural study of VP761
The structure of the native glycoprotein VP7 containing the domain
VP761 in its C-terminal region is known [17]. The solvent conditions to
solubilize the peptide VP761 were determined and optimized by moni-
toring the quality of the signal by 1D proton NMR (Fig. 6). The line
broadening of the resonances on the 1D proton NMR spectra of VP761
in 100% H2O, conﬁrmed that the peptide had a strong tendency to ag-
gregate in aqueous solutions (Fig. 6A). To overcome this problem,
VP761 was analyzed in a CDCl3/CD3OH (1:1, v/v) condition (Fig. 6B)
and in the presence of variable amounts of DPC (Fig. 6C–E) that were
previously shown to mimic the hydrophobicity of the membranes
[63–65], at different temperatures (Fig. 6E–G). Thus, it was possible to
perform 2D NMR studies of VP761 solubilized in CDCl3/CD3OH (1:1, v/v)
at 293K or in 100mMDPC at 323 K. Despite the circular dichroism exper-
iments revealed a lower ellipticity value and lower helical content at
pH 3.3 compared to pH 7.4, an acidic pH was chosen to work with DPC.
At this acidic pH the amide proton exchange rate is slower than that at
a pH close to the neutrality. In case the peptide has a strong tendency to
aggregate and because we are working in the presence of micelles, it al-
lows getting a sharper signal andmore intense peaks that facilitate the in-
terpretation of the NMR spectra. Another reason is that at physiological
pH, acidic and basic residues are negatively and positively charged, re-
spectively. The intermolecular interactions between these charges lead
to an aggregation of the peptide. At acidic pH, the protonation of the
basic and acidic residues prevents intermolecular interactions.
3.7. Proton NMR chemical shift assignment
The complete proton chemical shift assignment was achieved
(Supplementary data Fig. S1 and Supplementary data Tables S1) in
CDCl3/CD3OH (1:1, v/v) at 293 K and in 100 mM DPC at 323 K
(Supplementary data Fig. S2 and Supplementary data Table S2). Charac-
teristic signals showed that, in both conditions, the peptide was orga-
nized into two helical domains spanning residues Q280-M310 and
R315-Y324 in CDCl3/CD3OH (1:1, v/v) (Supplementary data Fig. S3A)
and residues T281-M310 and S316-F322 in DPC (Supplementary data
Fig. S3B). In both solvents, the ﬁrst helix is ﬂanked by two ﬂexible re-
gions S266-P279 and S311-S314 in CDCl3/CD3OH (1:1, v/v)
125
62
1000
500
250
15
7.5
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Fig. 5.Membrane destabilization by VP761. The peptide VP761 strongly destabilizes artiﬁ-
cial membranes and releases the ﬂuorescein contained in liposomes by perforating their
membranes. The increase in ﬂuorescence reached saturation at micromolar concentra-
tions of VP761 and depended on the concentration of VP761.
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environment (Supplementary data Fig. S3B). These results show that a
hydrophobic environment is necessary for peptide folding.Fig. 6. Solubilization of VP761 followed by 1D proton NMR. Only the amide and aromatic
proton region is represented. (A) In purewater at pH 3.3, the peptide appears to be aggre-
gated with large line broadening. (B) In a mixture of CDCl3/CD3OH (1:1, v/v), the peptide
seems to be structured with a large spreading of the chemical shifts. (C–E) The peptide is
structured when solubilized with increasing DPC concentrations (10 mM, 40 mM and
100 mM) at the temperature of 293 K and pH 3.3. (F–G). By increasing the temperature
to 323 K the quality of the signal is increased with a narrow linewidth.3.8. Structure of VP761 in CDCl3/CD3OH (1:1, v/v)
The structure of VP761 in CDCl3/CD3OH (1:1, v/v) was determined
using the hybrid distance geometry-simulated annealing method im-
plemented in XPLOR 3.84 [53,56,66]. Out of 100 calculated structures,
10 were selected according to their low overall energy and their low
number of distance violations. The reﬁned structure of VP761 exhibits
two α-helical domains. The ﬁrst one, Q280-M310, is ﬂanked by an un-
structured region S266-P279 and a ﬂexible turn S311-S314, and the sec-
ond one, R315-Y324, shows various orientations related to the ﬁrst one
(Fig. 7A). The calculated structures of VP761 are of good quality, with a
high degree of convergence (Table 1). The ﬁrst α-helix encompassing
amino acids Q280-M310 has an average rmsd of 0.81 ± 0.31 Å calculat-
ed on the backbone atoms, while the second α-helix R315-Y324 has an
average rmsd of 0.47 ± 0.12 Å. None of the structures exhibited a dis-
tance violation greater than 0.2 Å and all of them presented a good co-
valent geometry. The distribution of the ϕ, Ψ angles revealed that
76.3%, 20% and 3.7% of the residues were respectively found in the fa-
vored, additional and generously allowed regions and that none of the
ϕ,Ψ angles were located in non-favorable regions (Table 1). The analy-
sis of the largest helical domain Q280-M310, according to the nature of
the amino acid side chains, shows a hydrophilic side formed by residues
Q280, R283, R286, K290, K291, Q294, Y297, D301, Q305, Q308 and a hy-
drophobic one composed by residues T281, M284, M285, W289, W292,
W293, F296, V299, V300, V303, I306, I307,M310. These two sides deﬁne
an amphipathic helix (Fig. 7B).
3.9. Structure of VP761 in micelle environment
In a second step, the structure of VP761 was studied by NMR in DPC
micelles. Because of their zwitterionic head, DPC mimics well the cellA
C
B
Fig. 7. NMR structure of VP761 in CDCl3/CD3OH (1:1, v/v). (A) Superimposition of the 10
energetically most favorable structures of VP761 calculated using XPLOR-NIH [53]. Two
α-helical domains characterize the structure. The ﬁrst one, Q280-M310, is ﬂanked by
one unstructured region S266-P279 and a ﬂexible turn S311-S314 followed by the second
well deﬁned domain (R315-Y324). (B) Helix Q280-M310 shows amphipathic properties
with one hydrophobic face constituted by residues T281, M284, M285, W289, W292,
W293, F296, V299, V300, V303, I306, I307 and M310, colored in red and a hydrophilic
face formed by residues Q280, R283, R286, K290, K291, Q294, Y297, D301, Q305 and
Q308, colored in blue. (C) Secondary structures identiﬁed within VP761 in CDCl3/CD3OH
(1:1, v/v) from the analysis of the observed medium range NOEs.
Table 1
NMR restraints and structural statistics.
CD3OH/CDCl3 DPC
NMR derived distance restraints
Total 765 887
Intraresidue 363 563
Sequential (|i−j| = 1) 159 213
Medium-range (1 b |i−j| ≤4) 145 111
Long-range (|i-j| N5) 0 0
Hbonds 98
Distance violations
(N0.2 Å) 0 0
r.m.s.d.
From experimental distance restraints (Å) (1.212 − 1.328)×10−2 (1.348 − 2.077)×10−2
From idealized geometry
Bonds (Å) (1.222 − 1.458)×10−3 (2.718 − 3.095)×10−3
Angles (deg) (0.468 − 0.476) (0.417 − 0.488)
Improper angles (deg) (0.334 − 0.336) (0.934 − 1.145)
Potential energies (Kcal/mol)
ENOE (5.434 − 1.812) (8.067 − 19.138)
EVDW (0.692 − 8.607) ((−89.964) − (−170.835))
EBOND (1.560 − 2.221) (7.712 − 10.003)
EANGLES (62.742 − 64.763) (49.698 − 68.099)
EIMPROPERS (9.617 − 9.783) (20.298 − 28.1813)
ETOTAL (80.047 − 87.189) ((−1902.57) − (−1763.29))
Ramachandran analysis of residues
Favored region (%) 76.3% 72.60%
Additional allowed regions (%) 20.0% 23.00%
Generously allowed regions (%) 3.7% 2.21%
Disallowed regions (%) 0% 2.19%
r.m.s.d. on the backbone atoms (Å)
To mean structure Pairwise To mean structure Pairwise
Q280-M310 0.81 +/- 0.31 1.13 +/- 0.40
R315-Y324 0.47 +/- 0.12 0.36 +/- 0.13
Q280-M310/R315-Y324 3.35 +/- 1.10 3.84 +/- 1.01
Q280-Y324 3.44 +/- 1.00 3.95 +/- 0.99
E282-M310 0.73 +/- 0.25 1.10 +/- 0.37
L317-F322 2.26 +/- 0.14 0.79 +/- 0.28
E282-M310/L317-F322 3.73 +/- 1.53 6.86 +/- 2.40
E282-F322 3.98 +/- 1.38 5.40 +/- 2.12
2032 S. Elaid et al. / Biochimica et Biophysica Acta 1838 (2014) 2026–2035membrane hydrophobic environment and facilitates NMR studies by
solubilizing efﬁciently hydrophobic or amphipathic α-helices. VP761
was solubilized in the presence of 10 mM DPC and then incremented
amounts of DPC were added at 293 K until the 1D spectrum indicated
that equilibrium of VP761 structure in micelles was reached (Fig. 6C–E).
The temperature was then increased from 293 K to 323 K, which allowed
obtaining a narrower linewidth (Fig. 6E–G). The analysis of the identiﬁed
medium range NOEs in DPC conﬁrmed that VP761 is organized in two
helical domains with characteristic NOEs found for the two stretches
T281-I307 and S316-S319 (Supplementary data Fig. S3B), as observed in
CDCl3/CD3OH (1:1, v/v) (Supplementary data Fig. S3A). The structure of
VP761, calculated using the NMR restraints collected for the peptide in
100 mM DPC and at 323 K, is characterized by one helical domain
spanning residues T281-M310, followed by an unstructured domain
S311-R315 and ended by a second α-helix S316-F322 (Fig. 8). The
ﬁrst helix T281-M310 is well deﬁned with an average rmsd of 0.73
(±0.25) Å calculated on the backbone atoms for the eight best struc-
tures (Table 1 and Fig. 8A). The helix T281-M310 has amphipathic
characteristics with the amino acid side chains of R283, R286, K290,
Q294, Y297, D301, Q305, and Q308 forming a hydrophilic surface while
the residues T281, M285, W289, W293, F296, V300, V303, I306, and
M310 provide an uninterrupted hydrophobic one (Fig. 8B). The C-
terminal α-helix S316-F322 is less well-deﬁned in the presence of DPC
(Fig. 8C) than its counterpart R315-V326 in CDCl3/CD3OH (1:1, v/v)
(Fig. 7C).3.10. VP761 adopts a different structure when compared to its counterpart
in the whole VP7 protein
The structure of the VP761 domain, determined by NMR was then
compared to that of its counterpart in the X-ray structure of the native
VP7 [14,17], for which most of the polypeptide chain was determined,
giving an atomic model extending from residue 78 to residue 312. The
counterpart of VP761 in the X-ray structure of VP7 adopts a conforma-
tion consisting of a short β-sheet, β13 M284-I287 (in cyan Fig. 9A),
and an α-helix W292-M310 with a kink in its center between residues
D301 and Y302 (in magenta Fig. 9A) while the C-terminal domain of
VP7 spanning residues S316 to V326 is not observable and thus unde-
ﬁned (Fig. 9A). Thus, the NMR structure of VP761 containing two α-
helical domains T281-M310 and S316-F322, does not exhibit the same
3D organization (Fig. 9B). The structure of the peptide VP761 evolves de-
pending on whether it is embedded in the native protein VP7 (Fig. 9A)
or in its isolated form (Fig. 9B). The alignment of the sequences and sec-
ondary structures are shown in Fig. 9C.4. Discussion
Non-enveloped viruses, as rotaviruses, destabilize the host cell mem-
brane by processes that remain hypothetical although it is known that the
two outer capsid proteins VP4 and VP7 are involved at different levels in
CA B
Fig. 8.NMR structure of VP761 in DPC. (A) Superimposition of the eight energetically most
favorable structures of VP761 calculated with ARIA. The structure is characterized by two
α-helical domains, T281-M310 and S316-F322, separated by a ﬂexible region S311-
R315. The ﬁrst helix is preceded by an unstructured region, S266-Q280. (B) Helix T281-
M310 shows amphipathic properties with one hydrophobic face constituted by residues
M285, W289, W293, F296, V300, V303, I306 and M310, colored in red and a hydrophilic
face formed by residues R283, R286, K290, Q294, Y297, D301, Q305 and Q308, colored
in blue. The second helix S316-F322 in DPC is shorter than its counterpart R315-Y324 in
CDCl3/CD3OH (1:1, v/v). (C) Secondary structures identiﬁed within VP761 in DPC from
the analysis of the observed medium range NOEs.
A
C
Fig. 9. Comparison of the NMR structure of the C-terminal domain VP761 with its X-ray structu
termined by NMR in this study in a micellar environment. The corresponding domains in the X
V326, are colored in yellow, cyan, red and blue respectively. (C) Comparison of the secondary s
2033S. Elaid et al. / Biochimica et Biophysica Acta 1838 (2014) 2026–2035both virus attachment and in cell entry. Both VP4 and VP7, containmotifs
for binding members of the heterodimer α/β integrin family [20,67] and
the heat shock protein Hsc70 to lipid rafts [21]. The two viral proteins
VP4 and VP7 induce neutralizing antibodies that block rotavirus entry
[68], and the uncoating of VP7 is necessary for the ﬁnal steps of DLP deliv-
ery [69,70]. Moreover, the ESCRT complex seems to play a role in the
entry of the human and simian rotavirus in epithelial cells [71]. Inde-
pendent of the molecules recognized for attachment to the cell and
whatever the endocytic pathway followed, rotaviruses converge in
early endosomes and use multivesicular bodies to penetrate the cells
[71]. But ultimately, the mechanism by which the rotavirus enters the
cell remains unknown.
The native protein VP7 is unable to destabilize or permeabilize bio-
logical or artiﬁcial membranes. Here, using bioinformatics tools, we
show that, on the contrary, VP7 contains a domain, VP761, that is able
to destabilize or permeabilize membranes. When different concentra-
tions of VP761 are added to liposomes containing carboxyﬂuorescein,
the release of this ﬂuorescent molecule is observed, indicating loss of
membrane integrity (e.g., pore formation).
The interaction of VP761with an egg PC bilayer studied by PWR indi-
cates that 90% of the spectral changes are due to changes in mass of the
system with an apparent dissociation constant KD = 95 nM. This could
represent the ﬁrst steps of the interaction between the perforating
peptide VP761 and the membrane. The spectra obtained by ATR-FTIR
spectroscopy on the domain VP761 can be compared with the ATR
spectra published on the hΦ20 peptide [72], consisting of 20 alternating
alanine and leucine residues and two ﬂanking lysines at each terminus,
in interaction with POPC (lipid 1-palmitoyl-2-oleoyl-sn-glycero- 3
phosphocholine) bilayer. The hΦ20 peptide was mainly in α-helix and
the relative intensities of the amide I and amide II bands are similar to
those observed with the VP761 peptide. This is especially true for the
s-polarization spectra where the amide I and amide II bands haveB
re counterpart. (A) X-ray structure of the native protein VP7. (B) Structure of VP761 as de-
-ray structure and in the NMR structure, S266-R283, M284-I287, N288-M310, and R311-
tructures in the C-terminal domain of VP7 determined by X-ray crystallography and NMR.
2034 S. Elaid et al. / Biochimica et Biophysica Acta 1838 (2014) 2026–2035almost the same intensities. From these data, an angle of 33° with re-
spect to the normal membrane was evaluated for the hΦ20 peptide
[72]. One could hypothesize that a similar angle is formed for VP761 he-
lical part. Due to the fact that VP761 adopts other structures (although in
minority) than α-helix, this angle cannot be determined.
Circular dichroism and NMR structural studies in the presence of
DPC, a membrane-mimicking agent, showed that VP761 is predomi-
nantly organized into two alpha helical domains. The properties of
the peptide VP761 are mainly due to the presence of an amphipathic
α-helix Q280-M310 identiﬁed in its three-dimensional structure. The
amphipathic properties of this domain explain its tendency to aggregate
in polar solvents and account for its ability to interact with biological
and artiﬁcial membranes. Many amphipathic α-helical structures are
known to aggregate at the membrane surface, to insert into biological
membranes, to form pores and to destabilize them [73,74].
Spectroscopic methods as NMR experiments performed in micelle
environment or in CDCl3/CD3OH (1:1, v/v), circular dichroism achieved
at two different pHs or polarized ATR infrared spectroscopy revealed
that the isolated peptide VP761 folded into an alpha helical structure
with amphipathic properties. Moreover we showed that the VP761 do-
main structure depends on its environment, and that the isolated pep-
tide and the peptide embedded in the native protein adopt different
structures (NMR and X-ray data, respectively). The 3D structure of
VP761, as determined by NMR (Figs. 8 and 9B) in a DPC environment,
is different from its counterpart domain in the X-ray structure of VP7
bound to the Fab fragment of a neutralizing monoclonal antibody [17]
(Fig. 9A). The main differences consist ﬁrstly in a strand M284-I287 in-
volved in a β-sheet in the X-ray structure of VP7, that switches into an
α-helical conformation in VP761. Secondly, the helix T281-M310 identi-
ﬁed in the NMR structure is larger than the corresponding domain
W292-M310, in the X-ray structure, where a kink splits the helix into
two helical subdomains W292-D301 and Y302-M310. Thirdly, the
S311-V326 domain, undeﬁned in the X-ray structure of VP7, adopts a
shortα-helix conformation S316-F322 in the NMR structure. The struc-
tural rearrangement of VP761 seems to confer membranotropic proper-
ties to that peptide, consisting in membrane destabilization, while the
full protein VP7 does not. Thus, VP7 is not only involved in the control
of the transcriptional activity of the rotavirus particles [75,76] and in
cell attachment by interacting with integrin receptors [20,67], but
could also be implicated in other biological processes like membrane
permeabilization by release of membranotropic fragments. These ﬁnd-
ings on VP7 could underline the economy developed by the viruses to
use the same protein for different functions and minimize the size of
their genome and of the viral capsid, and they could be generalized to
other non-enveloped viruses, such as nodaviruses [77], reoviruses
[78], birnaviruses [31] and picobirnaviruses [79].
We have recently shown that pep46, one of the peptides present in
the virus capsid of the birnavirus, was able to induce pores into mem-
branes as an intermediate step of the birnavirus-penetration pathway
[31]. Pep46 forms a long amphipathic helix that inserts into the mem-
brane with its axis parallel to the surface of the membrane, during the
ﬁrst step of pore formation [31]. We have shown that VP761, a peptide
isolated from VP7 changes its structure, inserts into artiﬁcial mem-
branes and induces their permeabilization. We can speculate that
since rotaviruses bind trypsin [80], VP7 peptides may be produced
when the viruses enter the cell and thus participate to the process
used by rotaviruses to crossmembranes. Such an assertion still requires
the demonstration that peptides containing the amphipathic domain
T280-M310 are produced during rotavirus infection. Because cells are
infected by a reduced number of viruses, with an average number of vi-
ruses per cell close to 1 or lower, under these experimental conditions it
is difﬁcult to detect the virus particle. Thus, the physiological relevance
of our ﬁndings remains to be proven and does not allow us to claim a
role of this peptide in the mechanism of virus infectivity. Despite this,
additional techniques used in this study to elucidate the structure
strengthen our conclusions on the structure adopted by the peptide.This work contains information that we believe will be useful to other
researchers in the ﬁeld.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2014.04.005.
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